The	the	O	O	O	O
protective	protective	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
in	in	O	O	O	O
streptozotocin-induced	streptozotocin-induced	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

OBJECTIVE	objective	O	O	O	O
:	:	O	O	O	O
Diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
is	is	O	O	O	O
one	one	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
major	major	O	O	O	O
causes	causes	O	O	O	O
of	of	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
failure	failure	O	DISEASE	OTHERS	I
,	,	O	O	O	O
which	which	O	O	O	O
is	is	O	O	O	O
accompanied	accompanied	O	O	O	O
by	by	O	O	O	O
the	the	O	O	O	O
production	production	O	O	O	O
of	of	O	O	O	O
reactive	reactive	CHEMICALS	O	OTHERS	I
oxygen	oxygen	CHEMICALS	O	OTHERS	I
species	species	CHEMICALS	O	OTHERS	I
(	(	O	O	O	O
ROS	ros	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

Nrf2	nrf2	O	O	O	O
is	is	O	O	O	O
the	the	O	O	O	O
primary	primary	O	O	O	O
transcription	transcription	O	O	O	O
factor	factor	O	O	O	O
that	that	O	O	O	O
controls	controls	O	O	O	O
the	the	O	O	O	O
antioxidant	antioxidant	O	O	O	O
response	response	O	O	O	O
essential	essential	O	O	O	O
for	for	O	O	O	O
maintaining	maintaining	O	O	O	O
cellular	cellular	O	O	O	O
redox	redox	O	O	O	O
homeostasis	homeostasis	O	O	O	O
.	.	O	O	O	O

Here	here	O	O	O	O
,	,	O	O	O	O
we	we	O	O	O	O
report	report	O	O	O	O
our	our	O	O	O	O
findings	findings	O	O	O	O
demonstrating	demonstrating	O	O	O	O
a	a	O	O	O	O
protective	protective	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
against	against	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

RESEARCH	research	O	O	O	O
DESIGN	design	O	O	O	O
AND	and	O	O	O	O
METHODS	methods	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
explore	explore	O	O	O	O
the	the	O	O	O	O
protective	protective	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
against	against	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
using	using	O	O	O	O
human	human	O	O	O	O
kidney	kidney	O	O	O	O
biopsy	biopsy	O	O	O	O
tissues	tissues	O	O	O	O
from	from	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
,	,	O	O	O	O
a	a	O	O	O	O
streptozotocin-induced	streptozotocin-induced	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
model	model	O	O	O	O
in	in	O	O	O	O
Nrf2(-/-	nrf2(-/-	O	O	O	O
)	)	O	O	O	O
mice	mice	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
cultured	cultured	O	O	O	O
human	human	O	O	O	O
mesangial	mesangial	O	O	O	O
cells	cells	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
The	the	O	O	O	O
glomeruli	glomeruli	O	O	O	O
of	of	O	O	O	O
human	human	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
patients	patients	O	O	O	O
were	were	O	O	O	O
under	under	O	O	O	O
oxidative	oxidative	O	O	O	O
stress	stress	O	O	O	O
and	and	O	O	O	O
had	had	O	O	O	O
elevated	elevated	O	O	O	O
Nrf2	nrf2	O	O	O	O
levels	levels	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
animal	animal	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
Nrf2	nrf2	O	O	O	O
was	was	O	O	O	O
demonstrated	demonstrated	O	O	O	O
to	to	O	O	O	O
be	be	O	O	O	O
crucial	crucial	O	O	O	O
in	in	O	O	O	O
ameliorating	ameliorating	O	O	O	O
streptozotocin-induced	streptozotocin-induced	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
damage	damage	O	DISEASE	OTHERS	I
.	.	O	O	O	O

This	this	O	O	O	O
is	is	O	O	O	O
evident	evident	O	O	O	O
by	by	O	O	O	O
Nrf2(-/-	nrf2(-/-	O	O	O	O
)	)	O	O	O	O
mice	mice	O	O	O	O
having	having	O	O	O	O
higher	higher	O	O	O	O
ROS	ros	O	O	O	O
production	production	O	O	O	O
and	and	O	O	O	O
suffering	suffering	O	O	O	O
from	from	O	O	O	O
greater	greater	O	O	O	O
oxidative	oxidative	O	O	O	O
DNA	dna	O	O	O	O
damage	damage	O	O	O	O
and	and	O	O	O	O
renal	renal	O	DISEASE	OTHERS	I
injury	injury	O	DISEASE	OTHERS	I
compared	compared	O	O	O	O
with	with	O	O	O	O
Nrf2(+/+	nrf2(+/+	O	O	O	O
)	)	O	O	O	O
mice	mice	O	O	O	O
.	.	O	O	O	O

Mechanistic	mechanistic	O	O	O	O
studies	studies	O	O	O	O
in	in	O	O	O	O
both	both	O	O	O	O
in	in	O	O	O	O
vivo	vivo	O	O	O	O
and	and	O	O	O	O
in	in	O	O	O	O
vitro	vitro	O	O	O	O
systems	systems	O	O	O	O
showed	showed	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
Nrf2-mediated	nrf2-mediated	O	O	O	O
protection	protection	O	O	O	O
against	against	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
is	is	O	O	O	O
,	,	O	O	O	O
at	at	O	O	O	O
least	least	O	O	O	O
,	,	O	O	O	O
partially	partially	O	O	O	O
through	through	O	O	O	O
inhibition	inhibition	O	O	O	O
of	of	O	O	O	O
transforming	transforming	O	O	O	O
growth	growth	O	O	O	O
factor-beta1	factor-beta1	O	O	O	O
(	(	O	O	O	O
TGF-beta1	tgf-beta1	O	O	O	O
)	)	O	O	O	O
and	and	O	O	O	O
reduction	reduction	O	O	O	O
of	of	O	O	O	O
extracellular	extracellular	O	O	O	O
matrix	matrix	O	O	O	O
production	production	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
human	human	O	O	O	O
renal	renal	O	O	O	O
mesangial	mesangial	O	O	O	O
cells	cells	O	O	O	O
,	,	O	O	O	O
high	high	O	O	O	O
glucose	glucose	CHEMICALS	O	OTHERS	I
induced	induced	O	O	O	O
ROS	ros	O	O	O	O
production	production	O	O	O	O
and	and	O	O	O	O
activated	activated	O	O	O	O
expression	expression	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
and	and	O	O	O	O
its	its	O	O	O	O
downstream	downstream	O	O	O	O
genes	genes	O	O	O	O
.	.	O	O	O	O

Furthermore	furthermore	O	O	O	O
,	,	O	O	O	O
activation	activation	O	O	O	O
or	or	O	O	O	O
overexpression	overexpression	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
inhibited	inhibited	O	O	O	O
the	the	O	O	O	O
promoter	promoter	O	O	O	O
activity	activity	O	O	O	O
of	of	O	O	O	O
TGF-beta1	tgf-beta1	O	O	O	O
in	in	O	O	O	O
a	a	O	O	O	O
dose-dependent	dose-dependent	O	O	O	O
manner	manner	O	O	O	O
,	,	O	O	O	O
whereas	whereas	O	O	O	O
knockdown	knockdown	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
by	by	O	O	O	O
siRNA	sirna	O	O	O	O
enhanced	enhanced	O	O	O	O
TGF-beta1	tgf-beta1	O	O	O	O
transcription	transcription	O	O	O	O
and	and	O	O	O	O
fibronectin	fibronectin	O	O	O	O
production	production	O	O	O	O
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
This	this	O	O	O	O
work	work	O	O	O	O
clearly	clearly	O	O	O	O
indicates	indicates	O	O	O	O
a	a	O	O	O	O
protective	protective	O	O	O	O
role	role	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
in	in	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
,	,	O	O	O	O
suggesting	suggesting	O	O	O	O
that	that	O	O	O	O
dietary	dietary	O	O	O	O
or	or	O	O	O	O
therapeutic	therapeutic	O	O	O	O
activation	activation	O	O	O	O
of	of	O	O	O	O
Nrf2	nrf2	O	O	O	O
could	could	O	O	O	O
be	be	O	O	O	O
used	used	O	O	O	O
as	as	O	O	O	O
a	a	O	O	O	O
strategy	strategy	O	O	O	O
to	to	O	O	O	O
prevent	prevent	O	O	O	O
or	or	O	O	O	O
slow	slow	O	O	O	O
down	down	O	O	O	O
the	the	O	O	O	O
progression	progression	O	O	O	O
of	of	O	O	O	O
diabetic	diabetic	O	DISEASE	OTHERS	I
nephropathy	nephropathy	O	DISEASE	OTHERS	I
.	.	O	O	O	O

